CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $205.55M, above the global median of $18.73M
- FinancialsAltman Z-Score -0.92: distress zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.98BCNY892.10M · vs all stocks (USD)
Revenue (TTM)
702.17MCNY104.74M · vs all stocks (USD)
Profit Margin
-68.90%52-Week Change
-19.69%vs all stocks
Market Capitalization
5.98BCNY892.10M · vs all stocks (USD)
Enterprise Value
8.39BCNY1.25B · vs all stocks (USD)
Forward P/E
16.36xPrice to Sales (TTM)
8.46xEnterprise to Revenue
11.96xEnterprise to EBITDA
-99.75xGross Margin
10.97%Profit Margin
-68.90%Operating Margin
-51.83%Return on Assets (TTM)
-3.14%Revenue (TTM)
702.17MCNY104.74M · vs all stocks (USD)
Revenue per Share (TTM)
0.5410CNYUpdated Sep 18, 2026Quarterly Revenue Growth
-37.20%Gross Profit (TTM)
129.41MCNY19.30M · vs all stocks (USD)
EBITDA (TTM)
-84.16MCNY-12.55M · vs all stocks (USD)
Net Income (TTM)
-483.77MCNY-72.16M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-25.90%Operating Cash Flow (TTM)
59.69MCNY8.90M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.38BCNY205.55M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
38.14MCNYFY2025 · Dec 31, 2025Revenue
831.18MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
625.02MCNYFY2025 · Dec 31, 2025Gross Profit
206.16MCNYFY2025 · Dec 31, 2025Operating Income
-196.01MCNY-29.24M · vs all stocks (USD)
Pre-tax Income
-407.67MCNYFY2025 · Dec 31, 2025Income Tax Expense
48.52MCNYFY2025 · Dec 31, 2025Net Income
-456.18MCNYFY2025 · Dec 31, 2025EBIT
-215.73MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-8.74MCNYFY2025 · Dec 31, 2025Research & Development
39.69MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
231.42MCNYFY2025 · Dec 31, 2025Other Operating Expenses
22.02MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.54MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
191.93MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.3314CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.3314CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.30BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.30BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-456.18MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
26.19MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-32.15MCNYFY2025 · Dec 31, 2025Free Cash Flow
-173.83MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
278.36MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-456.18MCNYFY2025 · Dec 31, 2025Other Non-cash Items
200.97MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
42.19MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
180.87MCNYFY2025 · Dec 31, 2025Capital Expenditures
-141.69MCNYFY2025 · Dec 31, 2025Sale of Investments
27.03MCNYFY2025 · Dec 31, 2025Other Investing Activity
-60.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-174.66MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.09BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.55BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-99.06MCNYFY2025 · Dec 31, 2025Other Financing Charges
669.73MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
112.68MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.30BSharesUpdated Sep 18, 2026Float Shares
939.32MSharesUpdated Sep 18, 2026% Held by Insiders
35.54%vs all stocks
% Held by Institutions
4.95%vs all stocks
Total Cash (MRQ)
577.28MCNY86.11M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.4450CNYUpdated Sep 18, 2026Total Debt (MRQ)
3.00BCNY446.92M · vs all stocks (USD)
Current Ratio (MRQ)
0.3170xBook Value per Share (MRQ)
-0.1020CNYUpdated Sep 18, 2026Total Assets
5.71BCNY851.00M · vs all stocks (USD)
Total Current Assets
1.24BCNYFY2025 · Dec 31, 2025Total Liabilities
5.59BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.47BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.55BCNYFY2025 · Dec 31, 2025Total Current Liabilities
4.04BCNYFY2025 · Dec 31, 2025Cash
34.25MCNYFY2025 · Dec 31, 2025Cash Equivalents
311.92MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
346.16MCNYFY2025 · Dec 31, 2025Other Short-term Investments
178.91MCNYFY2025 · Dec 31, 2025Accounts Receivable
277.18MCNYFY2025 · Dec 31, 2025Inventory
255.43MCNYFY2025 · Dec 31, 2025Accounts Payable
468.82MCNYFY2025 · Dec 31, 2025Short-term Debt
1.61BCNYFY2025 · Dec 31, 2025Other Current Liabilities
50.34MCNYFY2025 · Dec 31, 2025Long-term Debt
1.35BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
94.39MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.30BCNYFY2025 · Dec 31, 2025Retained Earnings
-4.06BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
119.91MCNY17.89M · vs all stocks (USD)
52-Week Low
3.56CNYUpdated Sep 18, 202652-Week High
9.24CNYUpdated Sep 18, 202652-Week Change
-19.69%vs all stocks
50-Day MA
5.19CNYUpdated Sep 18, 2026200-Day MA
5.58CNYUpdated Sep 18, 2026Avg 10-Day Volume
44.07MSharesUpdated Sep 18, 2026Avg 30-Day Volume
103.93MSharesUpdated Sep 18, 2026Diluted EPS (TTM)
-0.3700CNYUpdated Sep 18, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score -0.92: distress zoneCritical
Altman Z-Score: -0.92
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $205.55M, above the global median of $18.73MNotable
Levered free cash flow (USD): 205,547,081.288Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Cloudbreak Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shenzhen YHLO Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Eis Eczacıbaşı İlaç ve Sanayi A.Ş.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Rigel Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Theravance Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ardelyx Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sana Biotechnology, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
China Isotope & Radiation Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ceribell, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Shenzhen SED Industry Co., Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone
Akebia Therapeutics Inc.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone
Lianchuang Electronic Technology Co. Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone